Clinical Study of Retagliptin Phosphate Combined With Metformin in the Treatment of Type 2 Diabetes
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 174 participants.
Also called NCT05054842
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 174 participants
- Registry
-
NCT05054842
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT05054842. Randomized; quadruple masking; primary purpose treatment. Start 2021-12-06 (actual); primary completion 2023-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Study of Retagliptin Phosphate Combined With Metformin in the Treatment of Type 2 Diabetes
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- Retagliptin phosphate tablets、metformin sustained-release tablets
- Intervention (Drug)
- Retagliptin phosphate placebo tablets、metformin sustained-release tablets
- Lead sponsor
- Jiangsu HengRui Medicine Co., Ltd.
Record details
- Record id
cardio:ct-nct05054842- Content hash
d50f23a9d8d943b158da0b6007da37803fb89c33455c2d82ab3cff1c124bb315